Pacific Edge Ltd
NZX:PEB

Watchlist Manager
Pacific Edge Ltd Logo
Pacific Edge Ltd
NZX:PEB
Watchlist
Price: 0.086 NZD -5.49% Market Closed
Market Cap: 69.8m NZD

P/OCF
Price to OCF

-3
Current
-4.6
Median
19.1
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-3
=
Market Cap
69.8m NZD
/
Operating Cash Flow
-23.2m NZD
Market Cap P/OCF
NZ
Pacific Edge Ltd
NZX:PEB
69.8m NZD -3
FR
Pharnext SCA
OTC:PNEXF
6T USD -220 366.8
US
Abbvie Inc
NYSE:ABBV
328.5B USD 17.4
US
Amgen Inc
NASDAQ:AMGN
146.8B USD 12.8
US
Gilead Sciences Inc
NASDAQ:GILD
122B USD 11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
109.8B USD -222.3
US
Epizyme Inc
F:EPE
94.1B EUR -510.5
AU
CSL Ltd
ASX:CSL
116.2B AUD 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60B USD 13.5
US
Seagen Inc
F:SGT
39.3B EUR -82.4
NL
argenx SE
XBRU:ARGX
30.5B EUR -403
 
NZ
Pacific Edge Ltd
NZX:PEB
Average P/OCF: 16
Negative Multiple: -3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -220 366.8
US
Abbvie Inc
NYSE:ABBV
17.4
US
Amgen Inc
NASDAQ:AMGN
12.8
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -222.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -510.5
AU
CSL Ltd
ASX:CSL
25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -82.4
NL
argenx SE
XBRU:ARGX
Negative Multiple: -403

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A